Sponsored by PINC AI™ Applied Sciences, a Division of Premier
Apr 2024
In this session, we'll discuss leveraging RWE to enhance diversity within clinical trials and expedite the translation of research findings into real-world clinical practice. Our expert panel will illuminate how RWE can address existing disparities in clinical trial participation, amplify the voices of underrepresented communities, and ultimately lead to more effective and equitable healthcare interventions.
Apr 2024
In this webinar, experts will characterize financial toxicity from the patient perspective, suggest potential frameworks for incorporation of financial toxicity into economic evaluation, and discuss areas where further research is necessary.
Sponsored by Inovalon
Apr 2024
Join Inovalon’s experts as they discuss the power of combining RCT with real-world data, through innovative data-linking techniques, to transform understanding of the patient journey to uncover invaluable insights into clinical and economic outcomes in the real-world.
Sponsored by AstraZeneca
Mar 2024
This panel will discuss different perspectives on the utilization of these principles to advance value frameworks that help timely access to transformative treatments for people with cancer.
Sponsored by FIFARMA
Feb 2024
During the webinar the speakers will present the FIFARMA W.A.I.T. indicator, which assesses the availability of innovative medicines for oncology and orphan diseases in 8 Latin American countries: Peru, Colombia, Chile, Mexico, Brazil, Costa Rica, Argentina, and Ecuador.
Dec 2023
This webinar focuses on important developments within the African continent. The main learning objectives are (1) to outline country experiences on rolling out digital health technologies, (2) discuss the role of big data analytics, and (3) describe the future prospects in the African context.
Dec 2023
This webinar will provide a brief background on tokenization and its benefits. It will focus on end-to-end considerations for tokenizing data of clinical trial participants and designing fit for purpose studies based on linked real-world datasets.
Nov 2023
The ISPOR HEOR Competencies Framework, originally published in 2020, provides a set of competencies to serve as a guide on the knowledge, attitudes, and behaviors needed to perform effectively in the HEOR discipline. As the HEOR field advances, so do the job types and the breadth of topics in which professionals must demonstrate competence.
Oct 2023
The purpose of this webinar is to address this topic from the patients' perspective, outline how patients can be involved in the development and implementation of digital health initiatives and the impact and value for the patient community, including more ethical, faster, effective, and appropriate outcomes.
Oct 2023
The aim of this webinar is to discuss real-life examples on how biosimilar adoption has positively impacted care and patient access to biological therapies, focusing on testimonies from patient, policy, and healthcare professional representatives. Speakers are invited to converse on what the tangible benefits are that biosimilars have delivered for patients, and how biosimilar availability has supported access to care and the implementation of optimized disease management initiatives.
Oct 2023
This webinar will address when and why external control arms (ECA) are used, the acceptable types of data and methods to build ECAs, and circumstances under which ECAs are accepted from regulatory and HTA bodies.
Sponsored by Lane Clark & Peacock LLP
Oct 2023
In this webinar, we will give an overview of LLMs and share practical advice and cutting-edge examples about how to use them to help carry out real-world evidence (RWE) studies. We will also show how integrating GPT into population health analytics enables complex real-world datasets to be explored using simple language queries to transform the way that decision makers use data to identify unmet health needs.
Sponsored by Optum
Sep 2023
This webinar is aimed at those who perform or use the results of real-world evidence (RWE) studies. It aims to describe the use of predictive analytics and machine learning for causal inference in the context of the extremes for disease populations: rare diseases and common conditions such as obesity.
Sep 2023
The multi-stakeholder panel in this webinar will discuss how to strike the balance between openness and security in the process of health data collection for the successful value assessment regarding digital solutions.
Sep 2023
This webinar will provide an educational opportunity for the ISPOR membership to learn about how distributional cost-effectiveness analysis (DCEA) can be applied in the US setting. This webinar will introduce the method, discuss the current state of foundational data in the US and highlight a recent case study to illustrate data sources that can be leveraged in more routine DCEA application.
Sep 2023
Stated preference surveys often involve communicating large volumes of complex and/or unfamiliar medical information to provide context for respondents. This webinar examines innovative uses of technology to advance discrete choice experiment (DCE) research within health preference research. They will explore the different technologies that can be integrated into preference surveys illustrating how technology can better inform and potentially engage respondents.
Sep 2023
This webinar will cover the opportunities and challenges of collecting real-world data (RWD) and generating real-world evidence (RWE) for making better decisions in healthcare, specifically in Health Technology Assessment (HTA).
Sep 2023
This webinar will introduce several strategies for communicating the results of your study. These strategies can be used regardless of study methodology (eg, chart reviews, database analyses, economic models) and publication type (eg, abstract, poster, manuscript, report). As the field of HEOR continues to proliferate, the need for timely, clear, concise publications has never been greater.
Sponsored by FIFARMA
Aug 2023
Value-Based Procurement (VBP) is a critical element of a value-based healthcare system, offering a transformative purchase approach that addresses underlying barriers to access to innovative treatments. Unlike the traditional procurement methods that focus primarily on cost containment, VBP considers multiple factors, including the unique circumstances of each country, such as local disease burden, health priorities, infrastructure, supply chain, ability to pay for healthcare, and budget processes.
Sponsored by FIFARMA
Jul 2023
This webinar will inaugurate the third edition of the series of webinars sponsored by FIFARMA on Value and Access to Innovation, and will be focused on exploring the relationship between health and the economy and how to ensure the long term healthcare system sustainability.
Jul 2023
This webinar aims to provide insights into the economic evaluation of digital health technology, which presents unique challenges compared to pharmaceuticals, healthcare services, and medical devices. In this webinar, you will learn about the current role of health economics and outcomes research in assessing the value of digital health technologies, as well as the impact of digital health interventions in today’s healthcare systems.
Jul 2023
In oncology, sequential use of treatments with different mechanisms of action is common practice to overcome cross-resistance . Over the past decade, treatment sequencing with novel immunotherapy and targeted agents has contributed to substantial improvement in clinical outcomes in cancer patients. However, such clinical practice introduces methodology challenges for HTA.
Jul 2023
With the public comment period open until July 2023, this webinar will also present ISPOR members with the opportunity to ask questions and provide comments that will help inform ISPOR’s response on the draft guidance 4 document.
Jun 2023
This webinar is based off discussions that were held at the 2023 ISPOR HTA Roundtable – Asia Pacific on 8 March 2023. The HTA Roundtable focused on how countries or jurisdictions in the Asia Pacific region are assessing digital health technologies. This webinar will provide perspectives from different stakeholders and jurisdictions on the status of digital health assessments in the region.
Jun 2023
This webinar is aimed at all those who undertake research and development as well as value assessment of therapies and diagnostics in the rare disease space. It aims to expose the “diagnostic odyssey” and explain why a definitive diagnosis is not only important for patients but also for those assessing value. Objectives are to 1) explain what can be done to improve diagnosis in rare diseases and 2) why it matters in the context of value assessment.
Sponsored by PINC AI™ Applied Sciences, a Division of Premier
Jun 2023
Join us as we discuss how the healthcare landscape is changing in technology and clinical trial innovation, including diversity improvement, leveraging real-world evidence, comparative arms, and decentralized clinical trials.
Apr 2023
In this forum, the OSM Special Interest Group has selected leaders in the field of health economics to describe their approach to OSMs. Mohsen Sadatsafavi will introduce the Peer Models Network and PRISM service as part of "Open-access modelling as a companion to open-source modelling” illustrated with an example implemented for Chronic Obstructive Pulmonary Disease (the Evaluation Platform in COPD (EPIC) model.)
Apr 2023
The webinar will provide an overview of past and current efforts in health equity, its role in health outcomes research, and its future implications in the field.
Mar 2023
In this webinar series, we will hear from patient representatives and FDA staff to learn what is covered in this guidance series and what these new guidances mean for patient-focused drug development and the HEOR community.
Sponsored by Inovalon
Feb 2023
This webinar will focus on how integrating social determinants of health (SDOH) data with claims-based research can provide an opportunity to improve treatment access and outcomes for under-represented populations through targeted research and strategic efforts.
Feb 2023
The workshop will use real-time polling to understand the audience’s experiences with data collection fraud online and the methods used to prevent and identify data collection fraud. We will encourage audience members to share their own strategies, learnings, and challenges.
Sponsored by Parexel
Feb 2023
Focusing on clinical neurosciences (CNS), and using first-hand experience from a Parkinson’s study, experts from Parexel discuss how to integrate eCOA science and sensor technology into clinical trials.
Feb 2023
This is part one of a two-part webinar series. The FDA is developing Patient-Focused Drug Development (PFDD) guidance to inform the inclusion of patient experience when developing new medical therapies and products. This is a four-part guidance series, with two final guidances released, a third draft guidance released and a fourth guidance under development.
Jan 2023
An ageing population means an urgent need for better and effective treatment for age-related illnesses. Despite billion-dollar investments for drug development for these conditions, especially neurogenerative diseases, there is a low success rate and it is a slow process.
Sponsored by ISPOR Student Network Education Committee
Dec 2022
The ISPOR Student Network is pleased to present this three-part webinar series as a guide for landing their first job out of school.
Sponsored by GSK
Dec 2022
In this webinar, representatives from different stakeholder groups (patients, physicians, health economists and industry) will discuss the value of increasing the use of non-OS endpoints in reimbursement decision-making to their stakeholder groups. Using the example of multiple myeloma, the speakers will discuss how and when non-OS endpoints should be used, to support a future in which assessments of novel therapies are more fit-for-purpose.
Nov 2022
Real-World evidence (RWE) has recently received increased attention to provide supplementary evidence to support health technology assessment (HTA) submissions, especially as another source of insight into the real-world performance of novel therapeutic products, particularly when traditional randomized controlled trials (RCTs) are impractical or lack generalizability.
Sponsored by MSD
Nov 2022
Organizado por el Consorcio de ISPOR América Latina, esta reunión virtual presentó actualizaciones de políticas de salud y economía de la salud (HEOR) y conto con la participación de reconocidos expertos en la región.
Sponsored by Charles River Associates
Oct 2022
Biosimilars offer great potential for the patients, payers and the whole society. However, there exist policy barriers which can hinder this potential. The debate will analyze the challenges and opportunities for biosimilars uptake in Europe, Middle East and Canada.
Oct 2022
Hacemos una cordial invitación a los estudiantes, nuevos profesionales, y todos aquello interesado en discutir las oportunidades de desarrollo profesional que ofrece el campo de la Economía de la Salud e Investigación de Resultados (HEOR) en América Latina. Esta mesa redonde ofrecerá la perspectiva de diferentes sectores como la industria, el gobierno, la academia y la Evaluación de Tecnologías de la Salud (HTA) considerando las experiencias de distintos países en la región.
Oct 2022
Many health systems in Africa are generally characterized by high burden of out-of-pocket payment by patients at the point of care and increased exposure of clients to catastrophic health payments. However, there are recent moves by many African countries to improve their health financing systems and institute health insurance in a bid to ensure universal health coverage.
Sponsored by FIFARMA
Oct 2022
This webinar will focus on discussing how to ensure access for the right patient, to the right treatment, at the right time. We invited Max Newton, Engagement Manager at IQVIA as guest speaker. Max worked on the development of the FIFARMA "Patients Waiting to Access Innovative Therapies (WAIT) Indicator survey"; he also is leading a similar survey in Europe, the "EFPIA WAIT indicator".
Sponsored by Evidera, a PPD Company
Oct 2022
This webinar will explore what the SUCRA is, demonstrate how it can be meaningfully impacted by network composition (even in simple networks), and suggest corrections to common errors in the reporting of SUCRAs.
Sponsored by Replica Analytics
Sep 2022
This webinar presents a brief tutorial on synthetic data generation, an overview of its privacy preserving properties, and then review the results from studies evaluating the validity of analyses using synthetic data.
Sep 2022
Deliberative processes for health technology assessment (HTA) are intended to facilitate participatory decision making, using discussion and open dialogue between stakeholders. Increasing attention is being given to deliberative processes, but guidance is lacking for those who wish to design or use them. Health Technology Assessment International (HTAi) and ISPOR initiated a joint task force that developed comprehensive guidance to address this gap. This webinar will be of benefit to all those involved in establishing or improving deliberative processes for HTA in local contexts.
Sep 2022
The Statistical Methods in Health Economics and Outcome Research Special Interest Group is pleased to present two webinars on Network Meta-Analysis (NMA). The first one is an introduction to NMA by Emma Hawe. The second will cover special topics in NMA by Sofia Dias. Both webinars will be moderated by Gian Luca Di Tanna. The second webinar will feature more advanced content than the first webinar.
Sep 2022
Asia Pacific regional markets, including but not limited to mainland China, Japan, South Korea and Taiwan, play increasingly important roles in global clinical development. Patient-centric endpoints via clinical outcome assessments (COAs) and electronic COAs (eCOAs), are getting more and more attention in clinical research design and execution.
Sponsored by Charles River Associates
Sep 2022
This webinar leverages recent global research conducted across 17 countries to provide an overview of the challenges and solutions to ensure the biosimilar benefits are sustainably delivered to the whole society. There will be a specific focus on the issues in Australia and comparing those against examples found globally. Implications for patients, society as well as a discussion of the learnings in terms of policy provisions and best practices that can help solving these issues will also be held.
Sep 2022
The Statistical Methods in Health Economics and Outcome Research Special Interest Group is pleased to present two webinars on Network Meta-Analysis (NMA). The first of two webinars will focus on the terms associated with network meta-analyses, how and why different comparisons are used, and the concepts, assumptions, and limitations associated with NMA. The first webinar is focused on an Introduction to NMA by Emma Hawe. The second will cover special topics in NMA by Sofia Dias. Both webinars will be moderated by Gian Luca Di Tanna.
Sep 2022
The webinar will define patient preferences, patient-reported outcomes and patient engagement, by describing their core defining features, how they differ from one another, and outlining the complementary roles that they may have in understanding what matters to patients. The speakers will then discuss how patient preferences, patient-reported outcomes and patient engagement can play a role in marketing authorization and health technology assessment, and ultimately, facilitate better care and access to care for patients.
Aug 2022
This webinar intends to provide an overview of Health Technology Assessment and current developments in Indian market. The webinar will help participants learn different aspects of HTA.
Sponsored by FIFARMA
Aug 2022
This is the Second webinar of the Value and Access to Innovation webseries sponsored by FIFARMA. The series are structured around FIFARMA's VAI working group workstreams: (1) Funding: what is the relation between health & the economy and how to ensure the long term healthcare system sustainability, (2) Value: what are the value frameworks used by decision makers in LatAm and what is the impact on patient access, (3) Adoption: how to ensure access for the right patient, to the right treatment, at the right time.
Jul 2022
The key success factor for digital health implementation is the information sharing across multiple stakeholders engaged in the clinical decision making. The COVID pandemic revealed numerous differences in how individual data are used in the process of the adoption of various digital health solutions in the healthcare systems across the globe.
Sponsored by FIFARMA
Jul 2022
This is the first webinar of the Value and Access to Innovation webseries sponsored by FIFARMA. The series are structured around FIFARMA's VAI working group workstreams.
Jun 2022
This webinar will aim to provide an educational opportunity for the ISPOR membership to learn about the methods for conducting distributional cost-effectiveness analysis (DCEA).
Sponsored by AstraZeneca
Jun 2022
For cancer drugs, payers often prefer to make decisions based on overall survival (OS) outcomes. However, it may take many years to collect OS data; this is particularly apparent in early-stage cancer and when an active therapy is highly effective at extending life.
Sponsored by Charles River Associates
Jun 2022
This webinar leverages recent global research conducted across 17 countries to provide an overview of the challenges and solutions to ensure the biosimilar benefits are sustainably delivered to the whole society.
May 2022
Sponsored by MDClone
May 2022
Real-world evidence has advanced health research over the past two or three decades. The challenges of procuring sufficient, high-quality real-world data, of unlocking the knowledge contained in the data, and of sharing information without compromising patient privacy are ever-present.
Sponsored by Merck & Co., known as MSD outside the United States and Canada
May 2022
Next-generation sequencing (NGS) is the key to precision medicine in oncology and delivers several benefits across the patient care pathway, from providing patients with a tailored therapeutic strategy, increasing efficiency in healthcare systems delivery of care, resulting in potential cost savings and benefits to future patients.
Apr 2022
Health systems in Asia Pacific regions are under tremendous pressure to deal with the rising costs, unequal access to service, and uneven quality of care. More and more healthcare systems across the region have increasingly embraced a value-based health care (VBHC) agenda. How can we maximize value for money and optimize patient outcomes? How should healthcare be delivered and reimbursed? In light of these issues, this webinar brings together a panel of experts to discuss the current situation of value-based payment in the Asia Pacific region and beyond, challenges and opportunities for VBHC implementation in the region.
Apr 2022
This fireside discussion led by the task force co-chairs will focus on the main changes from the original CHEERS and provide a quick live demonstration on how to use it.
Apr 2022
ISPOR publishes the Top 10 HEOR Trends reports as part of its horizon scanning and monitoring of the trends that affect healthcare decision making around the world. ISPOR gathers information from its members on the current and future importance of a broad range of topics related to health, health care, health policy and scientific research.
Sponsored by Biogen
Apr 2022
This session educates about the specific challenges of rare disease treatments in an HTA and discusses how Real-World Evidence Collection can address the data gap at the time of access decision.
Apr 2022
Speakers will discuss the many uses of COA data gathered during patient-focused drug development, including benefit/risk evaluation, HTA, access decisions, policy decisions, and clinician and patient decision-making.
Apr 2022
The key success factor for digital health implementation is the information sharing across multiple stakeholders engaged in the clinical decision making. The COVID pandemic revealed numerous differences in how individual data are used in the process of the adoption of various digital health solutions in the healthcare systems across the globe.
Mar 2022
This session will discuss trends in the HTA/Reimbursement environment in Latin America and the drivers for value-based health care (VBHC) implementation within the region. The potential benefits of VBHC, stakeholders’ roles in VBHC, contextual barriers and facilitators for VBHC implementation, and potential future impact of VBHC to healthcare in the region will be discussed by a panel of speakers.
Sponsored by Medtronic
Mar 2022
Experts from around the world will be sharing their experience about obesity treatment and reimbursement policies in their different countries. The event will consist of 7 expert presentations followed by a round table discussion with an opportunity for the audience to ask questions.
Jan 2022
This webinar led by the task force co-chairs will focus on the main changes from the original CHEERS and a provide a quick live demonstration on how to use it. They will also discuss how a patient and public participation group was involved in the revision process, the resources being developed to support CHEERS 2022, the proposals for its dissemination and the involvement of a wide range of journals in the publication of the statement.
Jan 2022
This webinar will be useful for researchers, regulators, academics, industry sponsors, and instrument developers in the clinical outcomes assessment (COA) field working on the development, evaluation, and implementation of performance outcome (PerfO) measures for use in capturing clinical benefits in treatment trials for medical label claims.
Jan 2022
This webinar emerges in the sequence of relevant topics highlighted in the ISPOR Science Strategy (particularly the Special Populations and Technologies and Health Economics, Access and Policy sections) and the Special Interest Group on biosimilars, by specifically reflecting on how to tackle inefficiencies of healthcare systems in the future with biosimilars.
Nov 2021
Consider payer decision making in the context of health preference research (HPR) in market access and health technology assessment (HTA). How does it fit together? What are the differences between patient preferences and public preferences as they apply to HTA? This webinar will provide a basic introduction to these issues and more.
Sponsored by Happy Life Technology
Oct 2021
There is increasing demand for real-world evidence (RWE) in healthcare decision making around the global, same as in China. Being the world’s second-largest market (after the US) and the only major market growing in the high single-digits annually, the regulatory and market access environment is evolving rapidly amid the fast development of healthcare sector in China.
Sep 2021
During this webinar, the speakers will present their respective studies on gene therapy in Duchenne muscular dystrophy, spinal muscular atrophy (SMA) and hemophilia. They will discuss the importance of the disease context, the qualitative research that influenced attribute selection, the selection of health preference method and design of the health preferences’ tasks, and how the study findings relate to the potential value of gene therapy.
Sponsored by Syneos Health
Sep 2021
In this webinar, experts will explore embedded clinical trials and their potential for effectively generating real world evidence, and review case studies illustrating best practice for these trials in action.
Sponsored by Certara
Sep 2021
Securing reimbursement from national payers is critical to your product’s commercial success. However, payers at the local and regional levels continue to get more authority to manage their own budgets. This makes engaging with payers and designing an effective strategy for value communication difficult as the concept of value can mean different things to different stakeholders.
Aug 2021
This webinar is a collaboration between ISPOR’s Health Preference Research Special Interest Group and the New Professionals Network.
Sponsored by Ontada
Aug 2021
They will address challenges faced by the pharmaceutical industry with clinical trials and the potential benefits that may be addressed with external controls, including lower costs, increased efficiency, time savings and potential ways to introduce real-world data elements for regulatory decisions.
Jul 2021
In this webinar, ISPOR Chapter members from the Arabic network will present the different funding channels in their countries, share experience about the current challenges and discuss possible opportunities that have not yet been explored.
Jul 2021
Panelists will discuss what approaches to use, describe the relevance for HTA organizations and how it might best be used, and will provide reflective thoughts on potential gaps, and where future efforts might be.
Jul 2021
During this webinar Dr Petros Pechlivanoglou and Dr Koen Degeling will provide an overview and hands-on demonstration of the opportunities of using R software for health economic analyses and modelling.
Sponsored by GenomiCare Biotechnology
Jun 2021
The potential to improve cancer care in China is clear, the journey to that destination is not. Here, we bring together a group of experienced RWE leaders, thinkers, and “doers" for an interactive, friendly, and informative discussion about the unique attributes of oncology care in China: diverse patient journeys, integration with traditional medicines, immature EHR integration across institutions, and the rapidly evolving regulatory and reimbursement environment.
Sponsored by Biogen
Jun 2021
A one-hour educational webinar on the implications of matched adjusted indirect treatment comparisons in rare disease, using SMA as an example. Webinar will provide both statistical and clinical perspective.
Sponsored by FIFARMA
May 2021
Esta sesión describirá el potencial de las soluciones digitales para transformar la atención en salud en América Latina, los obstáculos que siguen presentes y que impiden la amplia adopción y adaptación. Exploraremos lo que podemos aprender de los ejemplos de transformación digital en América Latina y otros países.
Sponsored by Medisafe
May 2021
In a healthcare world saturated with digital tools – and 40% of patients turning to digital resources – the best patient outcomes actually occur when personal, human-touch plays a notable part in acclimating patients on their prescription therapy. New research suggests that adding personal connection to digital health can increase adoption by 70%, leading to greater outcomes and faster healing.
Sponsored by FIFARMA
Apr 2021
Esta sesión, va a explorar modelos potenciales para generar inversiones a corto plazo para la atención en salud en América Latina, ya sea de nuevas fuentes de ingresos, opciones de financiación internacional o, inversionistas del sector privado. Incluiremos experiencias de países de América Latina así como modelos que se han mostrado prometedores en otros contextos, sectores o regiones que pueden contener lecciones aprendidas relevantes.
Mar 2021
This webinar will review each of the theme areas and focal points in the Strategy, the process by which they were generated, and their potential implications for future ISPOR activities.
Mar 2021
To help viewers better understand the region, this webinar brings together a panel of health experts across Latin America to provide multiple perspectives on the effects of COVID-19 in the healthcare of Latin America including regulatory change and innovation, public-private partnerships in health, digital transformation, regional and inter-regional cooperation and capacity building. Brought to you by ISPOR's Latin America Consortium.
Sponsored by FIFARMA
Mar 2021
En este evento educativo, escucharemos a dos expertos que han estado a la vanguardia de los esfuerzos en America Latina por implementar estos acuerdos, con el fin de balancear el acceso a nuevas tecnologías con un financiamiento sostenible. Héctor Castro (Líder global en financiamiento a la salud, tecnologías, datos e impacto, MSH) y Alicia Ferreira (Ex-directora del Fondo Nacional de Recursos) compartirán con nosotros ejemplos reales de cómo los Acuerdos de Entrada Gestionada se están implementando progresivamente en América Latina y, recomendaciones sobre cómo crear las bases para un camino mejorado hacia un mayor acceso a tratamientos para todos los latinoamericanos.
Sponsored by Biogen
Feb 2021
This educational webinar will describe factors that affect the assessment of the clinical and economic value of medical innovations, highlight specific issues with relevance to the societal value of treatments for AD, and place these issues in the context of future health technology assessments for AD treatments.
Feb 2021
In this webinar, expert speakers will explore the current digital healthcare landscape in Asia Pacific including regulatory, value assessment and reimbursement aspects, as well as future directions. Experiences with validation, evidence generation and reimbursement pathways for digital health solutions will be also shared through case studies.
Feb 2021
Many preference researchers have been quick to respond to this need and have conducted empirical COVID19 studies to better understand the value of health and health-related policies.
Feb 2021
This webinar will present an insightful exchange on best practices, challenges and opportunities for market access of biosimilars in different regions worldwide.
Dec 2020
This session will provide updates from the initiative including progress on the study registration site and the special task force on RWE protocol templates.
Dec 2020
In this presentation we will explore what the 4th Industrial Revolution is, how it impacts on the progressive movement towards digital transformation in our workplace. We will show that there is an inevitable convergence between the health ecosystem and the digital world.
Dec 2020
This webinar will discuss the rationale for the revision of the original Consolidated Health Economic Evaluation Reporting Standards (CHEERS) reporting guidelines and outline directions for the new reporting standards, as suggested by a Delphi survey.
Dec 2020
In this webinar, we will consider the apparent disconnect between HTA assessments of treatments within a specified location in a treatment sequence and clinical practice where a treatment sequence is tailored to the patient.
Dec 2020
This educational webinar explores some of the key issues relating to long-term evidence needs within the context of HTA in AD and considers what can be done in the short, medium, and long term to address evidence needs.
Nov 2020
The current regulatory and assessor landscape will be discussed including the European Union’s Innovative Medicines Initiative (IMI) and the Medical Device Innovation Consortium (MDIC). The task force is presenting their work to date with the request for feedback.
Nov 2020
This capstone webinar culminates the ISPOR-IVI series with a reflection on future direction and commitment needed to improve the scientific credibility and relevance of VA/HTA to pandemic preparedness.
Nov 2020
Determining resource utilization patterns, treatment and disease-related costs has become an important aspect of health outcomes research to guide health care resource allocation from a payer and policy decision-making perspectives.
Nov 2020
This webinar will define how Alzheimer’s disease affects underserved communities; share opportunities to create more equitable, ethical, and inclusive value frameworks; and educate on the community’s role in solving this problem.
Nov 2020
COVID-19 has brought home the importance of public health expertise and investment. How should VA/HTA address risks and benefits of public health policy interventions? How do we model the interactions between health and other sectors in our economy? What are the roles of the public vs. private sector in public health infrastructure and interventions? Are there policy implications for public health investment that VA/HTA can help frame?
Oct 2020
To advocate for a meaningful use of PROs to best reflect patient reality, patient advocates need to understand what PROs are, how PROs are being measured, and how they can bring the patient perspective into development, use and reporting of PRO measurements. This information will be presented across a 3-part webinar series
Oct 2020
This webinar seeks to explore some of these broader elements within the context of evolving value assessment and considers how they may meaningfully be incorporated to facilitate a more holistic approach to valuing medical innovation.
Oct 2020
To advocate for a meaningful use of PROs to best reflect patient reality, patient advocates need to understand what PROs are, how PROs are being measured, and how they can bring the patient perspective into development, use and reporting of PRO measurements. This information will be presented across a 3-part webinar series outlined below.
Oct 2020
The webinar will present an overview of societal benefits of biosimilars, how these are measured, how the United States (US) and select markets are tracking in attaining these benefits, and potential solutions for advancing the evidence of potential benefits into action.
Oct 2020
This webinar features a range of international speakers who will introduce several One Health-related topics as they pertain to HEOR, with a view gauging interest in the formation of an ISPOR Animal and One Health Special Interest Group (SIG).
Oct 2020
In this webinar, we will be discussing this issue in relation to cancer immunotherapy. An overview of the survival extrapolation methods which could be used for cancer immunotherapies will be presented along with an assessment of their strengths and limitations. Finally, the presenters will provide attendees with some pointers to help with the selection of appropriate survival extrapolation models for these agents.
Sep 2020
To advocate for a meaningful use of PROs to best reflect patient reality, patient advocates need to understand what PROs are, how PROs are being measured, and how they can bring the patient perspective into development, use and reporting of PRO measurements. This information will be presented across a 3-part webinar series.
Sep 2020
There is growing interest in the use of open source models (OSMs) for cost-effectiveness analysis. In this session, the leaders of a new Special Interest Group (SIG) will introduce the general ISPOR membership to OSMs, providing an overview of some of the perceived benefits and potential barriers to their adoption. The presenters will share the findings of a recent survey, relaying ISPOR members’ experiences and expectations about OSMs. The webinar will be used to help shape the direction of future events and the focus of the SIG.
Sep 2020
Sep 2020
Certara’s extensive experience with the recently accessible French administrative healthcare database (SNDS) has provided key insights into how the database can be used for a larger impact on patient access, health technology and public health assessments
Sep 2020
Evolving data from COVID-19 tell the story we already know: the impact of this disease affects people – especially people of color - disproportionately, both in terms of risk and prevalence, as well as access to care and outcomes. In considering VA/HTA approaches, as well as in discerning how to apply such findings, how must we address questions of ethics and equity?
Aug 2020
The methods, assumptions, and inputs to Value Assessment (VA) and Health Technology Assessment (HTA) are an evolving debate in the US, as we seek to balance questions of population health-driven resource allocation with the unique needs of health system, employer, payer, and societal decision-making and the emerging science of patient heterogeneity and precision medicine.
Aug 2020
In this session, experts from Latin America, Asia-Pacific and EMEA will discuss the role of HTA in UHC, including priority setting, coverage and financing, and share their experience in effective application of HTA to support designing benefits package for UHC while tackling the encountered challenges.
Aug 2020
In this session, expert speakers from the Asia Pacific region will discuss the importance, strengths and limitations of PROs, and use case studies to illustrate how to develop valid PRO measures and how PROs support research and decision-making.
Aug 2020
In this webinar, a holistic multi-stakeholder discussion about the stage of RWE and how its use could improve the performance of healthcare systems in LATAM, including priority setting, health technology assessment (HTA), effectiveness and safety measurement, and innovative access models.
Jul 2020
The initial webinar in the series will set the stage with an overview of current issues that the pandemic presents for the assessment of new technologies to prevent, treat, and potentially cure COVID-19, as well as the policy and implementation challenges.
Jul 2020
The far-reaching impacts of a pandemic on the US healthcare industry have tremendous implications for pharmaceutical and medical device utilization. Join this session to learn about the short-and long-term effects of a pandemic on healthcare utilization to inform pharmaceutical and medical device companies on how they may need to adjust their analyses of real-world data.
Jul 2020
The purpose of this webinar is to present the ISPOR definition of “patient engagement in research.” The definition was derived from a multi-step process, including a systematic review and qualitative analysis of existing definitions, and a multi-stakeholder review.
Jul 2020
When Does Mode of Data Collection Matter? Updated and Expanded Recommendations for Collecting PRO Measures Electronically in Clinical Trials
Jun 2020
This webinar will explore why and how to use qualitative research methods in conjunction with discrete choice experiments in healthcare. Speakers will discuss formative qualitative research for the identification and generation of attributes and levels and qualitative research for testing survey comprehension and decision-making processes.
May 2020
Virtual ISPOR 2020 Preconference Plenary Session - Keynote Address: COVID-19: Accelerating the Evidence to Inform our Response Mark McClellan, MD, PhD, Director, Duke-Margolis Center for Health Policy, Washington, DC, USA Panel: COVID-19: A Global Call to Action for Health Economics & Outcomes Researchers
Apr 2020
Health technology assessment (HTA) is gaining widespread acceptance and plays a vital role in healthcare decision making in many countries across the Asia Pacific region. In order to meet the changing demands of patients in light of new health technology innovations, HTA processes have needed to adapt. In this webinar, leading HTA experts from Thailand and South Korea will provide updates on recent developments in their countries’ HTA processes to strengthen patient access to innovative health technologies.
Apr 2020
This webinar will explore the value and challenges of linking administrative claims data to additional data sources in order to provide a more comprehensive look at the patient journey through a disease state. Data linkage types, techniques and best practices will be discussed.
Apr 2020
This timely webinar will highlight an initiative under development to create an insurance scheme in African countries to provide emergency financing for disease outbreaks. Country-level engagement to tailor the scheme to country needs and costing of outbreak responses to inform estimates of premiums will be specifically addressed.
Apr 2020
ISPOR—the professional society for health economics and outcomes research (HEOR), announced the publication of its 2020 Top 10 HEOR Trends report early this year. In the report, the Society has identified the top 10 HEOR trends that will shape the field and influence healthcare over 2020 and the near future.
Apr 2019
Feb 2019
Feb 2019
Jan 2019
Jan 2019
Feb 2018
Feb 2018
Jan 2018
Dec 2017
May 2017
Mar 2017
Mar 2017
Nov 2016
Sep 2016
Apr 2015
Mar 2015
Jan 2015
Dec 2014
Apr 2014
Apr 2014
Mar 2014
Mar 2014
Sep 2013
Jun 2013
Apr 2013
Mar 2013
Oct 2012
Apr 2012